Search
Searching Goglides
Loading matching companies, research, topics, and discussions.
Searching Goglides
Loading matching companies, research, topics, and discussions.
Search uses Goglides API results from the projection-backed discovery index. Private, draft, hidden, unpublished, and admin-only content stays out of public results.
Showing public results only.
SEC filings, financial facts, source resources, and Goglides workspace context for TJX Companies, Inc..
Signed-in searches appear here after you use search.
Tag facets appear after tag usage counts are rebuilt.
TJX reported FY2026 revenue of $60.37 billion, FY2026 net income of $5.49 billion and Q3 FY2026 revenue of $15.12 billion. The upgrade case depends on traffic, merchandise availability, buying discipline, inventory turns, wage control and international executi
OpenHims & Hers expanded its subscriber benefits bundle to ten partner brands. The update is not a direct revenue story yet; it is a retention, churn, and marketing-efficiency proof test.
OpenAgomAb Therapeutics is a newly public clinical-stage fibrosis biotech with no revenue, a Nasdaq ADS listing, an IPO-funded runway into the first half of 2029, and two 2026 data tracks that need to validate organ-restricted ALK5 inhibition.
OpenTag facets appear after tag usage counts are rebuilt.